17 results
424B3
IKT
Inhibikase Therapeutics Inc
4 Apr 23
Prospectus supplement
4:57pm
to participate in the 340B drug pricing program. The required 340B discount on a given product is calculated based on the AMP and Medicaid rebate amounts … governing drug pricing and reimbursement vary widely from country to country. For example, the European Union provides options for its member states
POS AM
IKT
Inhibikase Therapeutics Inc
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
to participate in the 340B drug pricing program. The required 340B discount on a given product is calculated based on the AMP and Medicaid rebate amounts … governing drug pricing and reimbursement vary widely from country to country. For example, the European Union provides options for its member states
424B4
kpd3q1m
17 Jun 21
Prospectus supplement with pricing info
4:31pm
DRS
m6c4z26mgv9
2 Jun 21
Draft registration statement
12:00am
10-K
vtvapn0zdzt41su
31 Mar 21
Annual report
2:14pm
424B4
uk9tpe7e99qme
28 Dec 20
Prospectus supplement with pricing info
6:04am
S-1
86jp33tgi0 ocd
23 Jul 20
IPO registration
12:28pm
DRS/A
vxet3
16 Oct 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next